Delivery Order SPE2DB20D3103-SPE2DB22FP7P4

Award Date 9/6/22
Potential Completion Date 9/7/22
Potential Value $16K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,677.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Levothyroxine 500 MCG vials, a critical pharmaceutical product. This is a firm fixed-price Delivery Order contract with a completion date of February 5, 2024. The contract was awarded on February 2, 2024 and does not have a set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,555.90 firm fixed-price contract is for the delivery of 4,563,268 units of the prescription drug Levothyroxine 175 mcg capsules. The contract has an ultimate completion date of January 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award is for the delivery of 4,560,797,370 vials of Levothyroxine 100 MCG to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,557.24 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a firm fixed price and an ultimate completion date of May 3, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop...
This federal contract award is for the delivery of Levothyroxine 150mcg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract, valued at $1,484.01, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with no set-aside designation,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $4,854.71 for Synthroid 50 mcg tablets. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports the Department of Defense. The contract has a completion date of February 6, 2024 and uses a firm fixed price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $36,995.36 firm-fixed-price delivery order covers the supply of Synthroid 125 mcg tablets to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,795,652 Synthroid 50 MCG tablets. The $1,049.64 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA) Troop Support Medical under their $999,999,999.00 Indefinite Delivery Contract (IDC) to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense (DoD) facilities worldwide. Amerisourcebergen, a large...
This federal contract award, valued at $1,679.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award covers the delivery of Synthroid 50 MCG tablets, a medication used to treat hypothyroidism. The contract has an ultimate completion date of December 5, 2024 and is structured as a firm fixed-price delivery order. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Synthroid 50 MCG tablets. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $6,077.15 and runs through February 2025. It is a firm fixed-price delivery order contract type. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Levothyroxine 150 MCG tablets. The delivery order has a firm fixed price of $2,304.88 and a period of performance through March 13, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division, is the prime contractor on this award. It is also the prime contractor on a larger $999,999,999 indefinite delivery contract...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FP7P4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,697.45 delivery order is for the supply of levothyroxine 100 mcg vials, with a completion date of September 7, 2022. The contract is a firm fixed-price Delivery Order, with no set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical commodities.

Generated 2/27/25, 10:35 AM